{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:16:09Z","timestamp":1770837369263,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"crossref"}]},{"name":"sinki University Hospital Research Funds"},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["Terveyden Tutkimuksen Toimikunta, Project 2666621"],"award-info":[{"award-number":["Terveyden Tutkimuksen Toimikunta, Project 2666621"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Hepatoblastoma is the most common pediatric liver tumor, and it primarily affects young children. Despite improved treatment results due to modern chemotherapy and advanced surgical techniques, there is urgent need to improve the long-term prognosis of hepatoblastoma patients. Elevated expression of transcription factor GATA4 has been associated with pro-tumorigenic functions in hepatoblastoma. Herein, we explored the effects of a novel series of GATA4-targeted compounds (3i-2010\u20133i-2014) in several hepatoblastoma cell models. To this end, we assessed cell viability (2D and 3D), caspase 3\/7 activity, cell cycle process with automated fluorescence microscopy, and RNA and protein expression using quantitative PCR, RNA-sequencing, and western blotting after treating cells with GATA4-targeted compounds. The GATA4-targeted compounds reduced hepatoblastoma cell viability but affected also healthy control cells when high doses were applied. Out of the five compounds used, the 3i-2012 was the most potent. This compound induced G0\/G1 phase cell cycle arrest, increased caspase activity, and resulted in changes in transcriptome of hepatoblastoma cells. The differentially expressed genes (DEGs) were associated with cell cycle regulation. Transcription factor target analysis demonstrated that a notable proportion of DEGs were likely regulated by GATA4. In conclusion, 3i-2012 decreases hepatoblastoma cell survival by disturbing cell cycle regulation in the tumor cells.<\/jats:p>","DOI":"10.1371\/journal.pone.0342565","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:29:13Z","timestamp":1770834553000},"page":"e0342565","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["GATA4-targeted compounds induce apoptosis and diminish viability of hepatoblastoma cells"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1592-8306","authenticated-orcid":true,"given":"Sini M.","family":"Kinnunen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Eloranta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9869-5706","authenticated-orcid":true,"given":"Marjut","family":"Pihlajoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika J.","family":"V\u00e4lim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saana","family":"Pohjavaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8974-6551","authenticated-orcid":true,"given":"Emilie","family":"Indersie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Cairo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarni","family":"Kuusinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Ruskoaho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Heikinheimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"1","key":"pone.0342565.ref001","first-page":"62","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: a population-based study","volume":"39","author":"J Feng","year":"2019","journal-title":"Cancer Commun (Lond)"},{"issue":"10","key":"pone.0342565.ref002","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29763","article-title":"Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States","volume":"69","author":"JA Kahla","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"pone.0342565.ref003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00383-022-05356-z","article-title":"Surgical management in hepatoblastoma: points to take","volume":"39","author":"M Murawski","year":"2023","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"pone.0342565.ref004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bjs.9681","article-title":"Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma","volume":"102","author":"R Venkatramani","year":"2015","journal-title":"Br J Surg"},{"issue":"22","key":"pone.0342565.ref005","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1200\/JCO.19.01067","article-title":"Outcome and late complications of hepatoblastomas treated using the Japanese study group for pediatric liver tumor 2 protocol","volume":"38","author":"E Hiyama","year":"2020","journal-title":"J Clin Oncol"},{"issue":"7","key":"pone.0342565.ref006","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1634\/theoncologist.2008-0011","article-title":"Liver tumors in children","volume":"13","author":"JB Litten","year":"2008","journal-title":"Oncologist"},{"issue":"1","key":"pone.0342565.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1262\/jrd.2012-100","article-title":"Expression and potential role of GATA factors in trophoblast development","volume":"59","author":"H Bai","year":"2013","journal-title":"J Reprod Dev"},{"key":"pone.0342565.ref008","article-title":"The emerging role of GATA transcription factors in development and disease","volume":"18","author":"MHFM Lentjes","year":"2016","journal-title":"Expert Rev Mol Med"},{"issue":"12","key":"pone.0342565.ref009","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/1947601911404223","article-title":"GATA transcription factors and cancer","volume":"1","author":"R Zheng","year":"2010","journal-title":"Genes Cancer"},{"issue":"20","key":"pone.0342565.ref010","doi-asserted-by":"crossref","DOI":"10.1242\/dev.164384","article-title":"GATA transcription factors in development and disease","volume":"145","author":"M Tremblay","year":"2018","journal-title":"Development"},{"issue":"4","key":"pone.0342565.ref011","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1074\/jbc.M310404200","article-title":"Hepatic erythropoietin gene regulation by GATA-4","volume":"279","author":"C Dame","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"pone.0342565.ref012","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082026","article-title":"Transcription control of liver development","volume":"10","author":"EC Tachmatzidi","year":"2021","journal-title":"Cells"},{"issue":"1","key":"pone.0342565.ref013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MPG.0b013e31822d52cf","article-title":"Transcription factor GATA-4 is abundantly expressed in childhood but not in adult liver tumors","volume":"54","author":"T Soini","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"pone.0342565.ref014","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695016","article-title":"Downregulation of transcription factor GATA4 sensitizes human hepatoblastoma cells to doxorubicin-induced apoptosis","volume":"39","author":"T Soini","year":"2017","journal-title":"Tumor Biology"},{"issue":"7","key":"pone.0342565.ref015","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318785498","article-title":"Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells","volume":"40","author":"T Soini","year":"2018","journal-title":"Tumor Biology"},{"issue":"47","key":"pone.0342565.ref016","doi-asserted-by":"crossref","first-page":"77890","DOI":"10.18632\/oncotarget.12839","article-title":"GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3","volume":"7","author":"Y Pei","year":"2016","journal-title":"Oncotarget"},{"issue":"18","key":"pone.0342565.ref017","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1021\/acs.jmedchem.7b00816","article-title":"Discovery of small molecules targeting the synergy of cardiac transcription factors GATA4 and NKX2-5","volume":"60","author":"MJ V\u00e4lim\u00e4ki","year":"2017","journal-title":"J Med Chem"},{"issue":"17","key":"pone.0342565.ref018","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1021\/acs.jmedchem.9b01086","article-title":"Synthesis, identification, and structure-activity relationship analysis of GATA4 and NKX2-5 protein-protein interaction modulators","volume":"62","author":"M Jumppanen","year":"2019","journal-title":"J Med Chem"},{"issue":"1","key":"pone.0342565.ref019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13287-023-03623-x","article-title":"Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound","volume":"15","author":"L Pohjolainen","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"pone.0342565.ref020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13287-021-02259-z","article-title":"GATA-targeted compounds modulate cardiac subtype cell differentiation in dual reporter stem cell line","volume":"12","author":"MJ V\u00e4lim\u00e4ki","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"pone.0342565.ref021","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s00204-018-2257-1","article-title":"Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds","volume":"92","author":"ST Karhu","year":"2018","journal-title":"Arch Toxicol"},{"key":"pone.0342565.ref022","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1038\/srep19103","article-title":"3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained","volume":"6","author":"M Zanoni","year":"2016","journal-title":"Sci Rep"},{"issue":"60","key":"pone.0342565.ref023","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.18632\/oncotarget.27237","article-title":"Volasertib preclinical activity in high-risk hepatoblastoma","volume":"10","author":"D Kats","year":"2019","journal-title":"Oncotarget"},{"key":"pone.0342565.ref024","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz446","article-title":"ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"AB Keenan","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"pone.0342565.ref025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer \u2014 from undruggable to reality","volume":"19","author":"JH Bushweller","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"pone.0342565.ref026","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/pbc.24171","article-title":"Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: stable radiographic disease with decreased AFP","volume":"59","author":"AM Marsh","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"pone.0342565.ref027","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00383-021-05043-5","article-title":"Establishment of childhood hepatoblastoma xenografts and evaluation of the anti-tumour effects of anlotinib, oxaliplatin and sorafenib","volume":"38","author":"D Yang","year":"2022","journal-title":"Pediatr Surg Int"},{"key":"pone.0342565.ref028","doi-asserted-by":"crossref","first-page":"550132","DOI":"10.3389\/fonc.2020.01138","article-title":"Chloroquine Triggers Cell Death and Inhibits PARPs in Cell Models of Aggressive Hepatoblastoma","volume":"10","author":"K Eloranta","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"pone.0342565.ref029","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2016.00022","article-title":"Hepatoblastoma: A need for cell lines and tissue banks to develop targeted drug therapies","volume":"4","author":"RR Rikhi","year":"2016","journal-title":"Front Pediatr"},{"issue":"1","key":"pone.0342565.ref030","doi-asserted-by":"crossref","first-page":"16810","DOI":"10.1038\/s41598-022-20769-5","article-title":"CDK4\/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1\/S transition","volume":"12","author":"S Kim","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0342565.ref031","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1469-7580.2008.00931.x","article-title":"G1 to S phase cell cycle transition in somatic and embryonic stem cells","volume":"213","author":"I Neganova","year":"2008","journal-title":"J Anat"},{"issue":"17","key":"pone.0342565.ref032","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1128\/MCB.00717-08","article-title":"GATA4 is a direct transcriptional activator of cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium","volume":"28","author":"A Rojas","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"1","key":"pone.0342565.ref033","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41598-019-39078-5","article-title":"Nkx2-5 Second Heart Field Target Gene Ccdc117 Regulates DNA Metabolism and Proliferation","volume":"9","author":"AJ Horton","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0342565.ref034","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00204-020-02711-8","article-title":"GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes","volume":"94","author":"ST Karhu","year":"2020","journal-title":"Archives of Toxicology"},{"issue":"12","key":"pone.0342565.ref035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144145","article-title":"Nuclear receptor-like structure and interaction of congenital heart disease-associated factors GATA4 and NKX2-5","volume":"10","author":"S Kinnunen","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"pone.0342565.ref036","first-page":"2235","article-title":"Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart","volume":"13","author":"RJ Arceci","year":"1993","journal-title":"Molecular and Cellular Biology"},{"issue":"5","key":"pone.0342565.ref037","first-page":"3115","article-title":"A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription","volume":"14","author":"C Grepin","year":"1994","journal-title":"Molecular and Cellular Biology"},{"issue":"2","key":"pone.0342565.ref038","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ab.2012.10.010","article-title":"Stain-Free technology as a normalization tool in Western blot analysis","volume":"433","author":"A G\u00fcrtler","year":"2013","journal-title":"Anal Biochem"},{"key":"pone.0342565.ref039","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4419-6199-0_9","article-title":"Analysis of cellular DNA content by flow and laser scanning cytometry","volume":"676","author":"Z Darzynkiewicz","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"pone.0342565.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A free online platform for data visualization and graphing","volume":"18","author":"D Tang","year":"2023","journal-title":"PLoS One"},{"key":"pone.0342565.ref041","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Y Liao","year":"2019","journal-title":"Nucleic Acids Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:29:24Z","timestamp":1770834564000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342565"}},"subtitle":[],"editor":[{"given":"Consolato M.","family":"Sergi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0342565","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]}}}